QQQ   362.18 (-2.21%)
AAPL   142.78 (-1.78%)
MSFT   285.70 (-2.88%)
FB   342.64 (-3.09%)
GOOGL   2,740.31 (-2.88%)
TSLA   784.08 (-0.92%)
AMZN   3,327.15 (-2.31%)
NVDA   209.24 (-3.40%)
BABA   153.20 (+2.01%)
NIO   35.46 (-3.56%)
CGC   14.34 (-2.52%)
GE   106.72 (+1.30%)
MU   74.14 (-1.38%)
AMD   102.75 (-5.00%)
T   27.32 (-0.29%)
F   14.47 (+2.19%)
ACB   6.85 (+7.20%)
DIS   175.75 (-1.41%)
PFE   43.25 (-0.73%)
BA   220.38 (-1.69%)
AMC   37.93 (-3.49%)
QQQ   362.18 (-2.21%)
AAPL   142.78 (-1.78%)
MSFT   285.70 (-2.88%)
FB   342.64 (-3.09%)
GOOGL   2,740.31 (-2.88%)
TSLA   784.08 (-0.92%)
AMZN   3,327.15 (-2.31%)
NVDA   209.24 (-3.40%)
BABA   153.20 (+2.01%)
NIO   35.46 (-3.56%)
CGC   14.34 (-2.52%)
GE   106.72 (+1.30%)
MU   74.14 (-1.38%)
AMD   102.75 (-5.00%)
T   27.32 (-0.29%)
F   14.47 (+2.19%)
ACB   6.85 (+7.20%)
DIS   175.75 (-1.41%)
PFE   43.25 (-0.73%)
BA   220.38 (-1.69%)
AMC   37.93 (-3.49%)
QQQ   362.18 (-2.21%)
AAPL   142.78 (-1.78%)
MSFT   285.70 (-2.88%)
FB   342.64 (-3.09%)
GOOGL   2,740.31 (-2.88%)
TSLA   784.08 (-0.92%)
AMZN   3,327.15 (-2.31%)
NVDA   209.24 (-3.40%)
BABA   153.20 (+2.01%)
NIO   35.46 (-3.56%)
CGC   14.34 (-2.52%)
GE   106.72 (+1.30%)
MU   74.14 (-1.38%)
AMD   102.75 (-5.00%)
T   27.32 (-0.29%)
F   14.47 (+2.19%)
ACB   6.85 (+7.20%)
DIS   175.75 (-1.41%)
PFE   43.25 (-0.73%)
BA   220.38 (-1.69%)
AMC   37.93 (-3.49%)
QQQ   362.18 (-2.21%)
AAPL   142.78 (-1.78%)
MSFT   285.70 (-2.88%)
FB   342.64 (-3.09%)
GOOGL   2,740.31 (-2.88%)
TSLA   784.08 (-0.92%)
AMZN   3,327.15 (-2.31%)
NVDA   209.24 (-3.40%)
BABA   153.20 (+2.01%)
NIO   35.46 (-3.56%)
CGC   14.34 (-2.52%)
GE   106.72 (+1.30%)
MU   74.14 (-1.38%)
AMD   102.75 (-5.00%)
T   27.32 (-0.29%)
F   14.47 (+2.19%)
ACB   6.85 (+7.20%)
DIS   175.75 (-1.41%)
PFE   43.25 (-0.73%)
BA   220.38 (-1.69%)
AMC   37.93 (-3.49%)
OTCMKTS:UCBJY

UCB Stock Forecast, Price & News

$56.19
+0.09 (+0.16 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$55.19
$56.19
50-Day Range
$52.59
$59.15
52-Week Range
$44.41
$59.73
Volume15,052 shs
Average Volume20,658 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive UCBJY News and Ratings via Email

Sign-up to receive the latest news and ratings for UCB and its competitors with MarketBeat's FREE daily newsletter.


UCB logo

About UCB

UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:UCBJY
CIK
N/A
Employees
7,820
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.42 out of 5 stars

Analyst Opinion: 2.4Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












UCB (OTCMKTS:UCBJY) Frequently Asked Questions

Is UCB a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UCB in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UCB stock.
View analyst ratings for UCB
or view top-rated stocks.

What stocks does MarketBeat like better than UCB?

Wall Street analysts have given UCB a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UCB wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting UCB?

UCB saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 6,500 shares, an increase of 103.1% from the August 15th total of 3,200 shares. Based on an average daily volume of 17,800 shares, the short-interest ratio is currently 0.4 days.
View UCB's Short Interest
.

How has UCB's stock price been impacted by COVID-19?

UCB's stock was trading at $50.3225 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, UCBJY stock has increased by 11.7% and is now trading at $56.19.
View which stocks have been most impacted by COVID-19
.

How often does UCB pay dividends? What is the dividend yield for UCB?

UCB declared a dividend on Friday, April 30th. Investors of record on Monday, May 10th will be given a dividend of $1.4382 per share on Wednesday, May 19th. This represents a dividend yield of 3.08%. The ex-dividend date is Friday, May 7th.
View UCB's dividend history
.

What price target have analysts set for UCBJY?

8 brokerages have issued 12-month price targets for UCB's shares. Their forecasts range from $52.84 to $52.84. On average, they anticipate UCB's share price to reach $52.84 in the next year. This suggests that the stock has a possible downside of 6.0%.
View analysts' price targets for UCB
or view top-rated stocks among Wall Street analysts.

Who are UCB's key executives?

UCB's management team includes the following people:
  • Jean-Christophe Tellier, Chief Executive Officer & Executive Director
  • Sandrine Dufour, Chief Financial Officer & Executive Vice President
  • Iris Löw-Friedrich, Chief Medical Officer & EVP-Development
  • Dhavalkumar Patel, Chief Scientific Officer & Executive VP
  • Herman de Prins, Chief Information Officer

What is UCB's stock symbol?

UCB trades on the OTCMKTS under the ticker symbol "UCBJY."

How do I buy shares of UCB?

Shares of UCBJY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UCB's stock price today?

One share of UCBJY stock can currently be purchased for approximately $56.19.

How many employees does UCB have?

UCB employs 7,820 workers across the globe.

What is UCB's official website?

The official website for UCB is www.ucb.com.

Where are UCB's headquarters?

How can I contact UCB?

UCB's mailing address is Allee de la Recherche, 60, Anderlecht, Bruxelles Capitale 1070. The company can be reached via phone at (322) 559-9999.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.